2025-10-23 - Analysis Report
Okay, here's an analysis of Procter & Gamble (PG) based on the data you provided, formatted as requested:

## Procter & Gamble (PG) Stock Analysis

**Company Overview:** Procter & Gamble Co is a multinational consumer goods corporation that provides a wide range of branded consumer packaged goods.

### 1. Performance vs. S&P 500 (VOO)

*   **PG Cumulative Return:** 31.93%
*   **VOO Cumulative Return:** 99.09%
*   **Absolute Divergence:** -65.3%
*   **Relative Divergence:** 3.9%

**Analysis:** PG has significantly underperformed the S&P 500. The relative divergence indicates PG's underperformance is near its historical worst relative to the S&P 500 based on your provided data's range.

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha | Beta | Cap(B) |
|------------|--------|--------|-------|------|--------|
| 2015-2017  | 21.0%  | 7.9%   | -8.0% | 0.0  | 215.9  |
| 2016-2018  | 9.0%   | 67.3%  | -6.0% | 0.1  | 216.0  |
| 2017-2019  | 24.0%  | 70.4%  | 2.0%  | 0.3  | 293.4  |
| 2018-2020  | 27.0%  | 78.8%  | 4.0%  | 0.4  | 326.9  |
| 2019-2021  | 41.0%  | 78.8%  | -5.0% | 0.5  | 384.3  |
| 2020-2022  | 13.0%  | 79.4%  | 13.0% | 0.6  | 356.1  |
| 2021-2023  | 26.0%  | 79.4%  | 24.0% | 0.4  | 344.3  |
| 2022-2024  | 9.0%   | 79.4%  | -12.0%| 0.4  | 393.9  |
| 2023-2025  | -12.0% | 80.1%  | -76.0%| 0.2  | 356.2  |

**Analysis:**

*   **Alpha:**  PG's alpha is highly variable, with significant negative values in some periods (especially recently).  This indicates PG's performance is not closely correlated with the overall market.
*   **Beta:** Beta values are relatively low, suggesting PG is less volatile than the S&P 500.
*   **CAGR:** Wide range of CAGR values from negative to positive.
*   **MDD:** High MDD values could mean the provided data needs adjustments

### 2. Recent Stock Price Movement

*   **Current Price:** 151.62
*   **Last Market Data:**
    *   **Price:** 152.2
    *   **Previous Close:** 151.62
    *   **Change:** 0.38
*   **5-Day Moving Average:** 150.4
*   **20-Day Moving Average:** 151.18
*   **60-Day Moving Average:** 154.38

**Analysis:** The stock is trading above its 5-day and 20-day moving averages but below its 60-day moving average. The recent price increase (change of 0.38) suggests a minor upward trend.

### 3. Technical Indicators & Outlook

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 45.89
*   **PPO:** 0.1954
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (6 shares - Very Safe - MRI:0.90) (Cash Ratio: 0% on 2025-10-20)
*   **Recent (20-day) Relative Divergence Change:** -2.0 (Negative - Short-term Decrease)
*   **Expected Return:** 61.7% (Long-term, vs. S&P 500)

**Analysis:**

*   The MRI suggests the market environment is conducive to investment.
*   The RSI is near the neutral level, not indicating overbought or oversold conditions.
*   The negative change in relative divergence indicates a recent weakening in PG's performance relative to the S&P 500.
*   A Long-term (2 years) of 적립 투자할 경우 예상되는 S&P 500대비 초과 수익률 is 61.7%.

### 4. Recent News & Events

*   **Positive:** Broker recommendations to invest in PG and Jim Cramer's positive sentiment.
*   **Earnings:** upcoming Q1 earnings release
*   **External:** General market news about Tesla, IBM, Krispy Kreme, and a corporate governance forum.

**Analysis:** The news sentiment appears moderately positive, with analyst recommendations supporting investment in PG.

### 4-2) Analyst Opinions

*   **Consensus:** Buy (Mean rating of 2.04)
*   **Target Price:** Average target price of $168.64 (potential upside).

**Analysis:** Analyst ratings and target prices suggest potential for price appreciation.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-04-24 | 1.58 | 19.78 B$ |
| 2025-01-22 | 1.94 | 21.88 B$ |
| 2024-10-18 | 1.65 | 21.74 B$ |
| 2024-04-19 | 1.56 | 20.20 B$ |
| 2025-04-24 | 1.56 | 20.20 B$ |

**Analysis:**
*   The EPS and sales data seem to be stable.

### 6. Financial Information

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-06-30 | \$20.89B   | 49.11%        |
| 2025-03-31 | \$19.78B   | 50.98%        |
| 2024-12-31 | \$21.88B   | 52.39%        |
| 2024-09-30 | \$21.74B   | 52.06%        |
| 2024-06-30 | \$20.53B   | 49.60%        |

| Quarter    | Equity     | ROE     |
|------------|------------|---------|
| 2025-06-30 | \$52.01B   | 6.95%   |
| 2025-03-31 | \$52.27B   | 7.21%   |
| 2024-12-31 | \$51.17B   | 9.05%   |
| 2024-09-30 | \$51.84B   | 7.64%   |
| 2024-06-30 | \$50.29B   | 6.24%   |

**Analysis:**

*   **Revenue:**  Revenue is relatively stable with some quarter-to-quarter fluctuations.
*   **Profit Margin:** Profit margins are reasonably high and consistent.
*   **Equity:** Equity is stable.
*   **ROE:** ROE fluctuates, peaking in the 2024-12-31 quarter, indicating fluctuating profitability relative to shareholder equity.

### 7. Overall Analysis & Recommendation

**Summary:** PG has underperformed the S&P 500 significantly, and that underperformance is near its worst relative level based on recent history. The stock is currently trading around its short-term moving averages.  Technical indicators suggest a potentially neutral to slightly positive outlook. Analyst opinions are generally favorable, with a consensus "Buy" rating and a potential upside based on target prices. Recent news is mixed but leans positive. The company exhibits stable revenue and profit margins, with fluctuating ROE.

**Recommendation:**  Given the underperformance relative to the S&P 500, investors should carefully weigh the potential upside suggested by analysts and technical indicators against the recent negative divergence and historical underperformance. The MRI indicates a generally favorable market environment, but PG-specific factors warrant caution.
